Marcel H Elissalde, Jr

Title: Marcel H. Elissalde, Jr.: Innovator in Monoclonal Antibody Detection

Introduction: Marcel H. Elissalde, Jr. is an accomplished inventor based in College Station, TX, recognized for his contributions to the field of monoclonal antibodies. With a patent to his name, he has made significant strides in developing methods for detecting salinomycin, a compound of interest in veterinary medicine.

Latest Patents: Elissalde holds a patent titled "Monoclonal antibodies to salinomycin and method for detecting the same." This innovation involves hybridoma cell lines that produce and secrete monoclonal antibodies capable of binding to salinomycin. The antibodies exhibit impressive sensitivity, allowing for the detection of salinomycin levels as low as approximately 0.174 to about 0.793 nanograms. Such capabilities are invaluable for the precise detection and quantitative determination of salinomycin in various samples, particularly in animal tissue and feed material.

Career Highlights: Marcel H. Elissalde, Jr. has dedicated his career to advancing biotechnology and improving detection methods in agricultural practices. His work has not only contributed to scientific advancements but has also practical applications within the veterinary industry, ensuring safer animal products for consumption.

Collaborations: Throughout his career, Elissalde has collaborated with notable colleagues such as Larry H. Stanker and Ross C. Beier. Together, they have contributed to groundbreaking research and innovations, helping to propel advancements in the detection of veterinary medicines.

Conclusion: Marcel H. Elissalde, Jr. stands as a noteworthy figure in the field of biotechnology, particularly through his innovative work on monoclonal antibodies. His patent demonstrates a significant leap forward in detecting salinomycin, showcasing the essential role of inventors in enhancing safety and accuracy in agricultural practices.